search icon
  • Print
  • ShareThis
  • Text Size


In order to add a post to the discussion forum you need to be an IDSA member. If you are an IDSA member, please login now. Please read our Discussion Forum Guidelines and Terms of Use before joining.

Hepatitis C

Welcome to Hepatitis C Management Discussion Board! The Hepatitis C Management Discussion Board provides Infectious Disease Clinicians a platform to connect with colleagues to exchange information, case studies, complications, and new developments on matters concerning hepatitis C treatment and management. Certain case studies will be developed into clinical vignettes and will be available to Infectious Disease Clinicians for future reference. Please be respectful of all participants and their respective comments. Please read our Terms of Use and Discussion Forum Guidelines.

 

Any diagnostic or therapeutic recommendations and all opinions presented are those of the individual contributor. They do not necessarily represent the views of IDSA. The reader assumes all risks in using this information. The IDSA Hepatitis C Discussion Forum is in full compliance with HIPPA. IDSA bears no responsibility for the accuracy of participant comments and will bear no legal liability for discussion results.

If a participant wishes to post an issue on the IDSA Hepatitis C Discussion Forum, the participant is strongly urged to provide contact information for possible offline discussion via phone or email concerning the posted issue.


RSS Feed Search Category View 
Drug Therapy
  Topics Topic Starter Replies Views Last Post
AbbVie Announces Positive Phase III Results ThomasKim 0 5 Friday, April 11, 2014 1:52 PM 
Gilead Next Generation Combination Pill ThomasKim 0 52 Monday, March 24, 2014 1:01 PM 
Gilead says payers feel comfortable with the cost of Sovaldi ThomasKim 0 222 Friday, February 14, 2014 1:06 PM 
FDA approves Sovaldi for chronic hepatitis C ThomasKim 0 631 Monday, December 9, 2013 10:21 AM 
Indication and Usage of Olysio (simeprevir) for the Treatment of Chronic Hepatitis C ThomasKim 0 657 Monday, November 25, 2013 2:38 PM 
J&J, Medivir gain FDA OK for new hep C therapy simeprevir ThomasKim 0 606 Monday, November 25, 2013 1:08 PM 
J&J wins FDA panel blessing for hep C blockbuster hopeful ThomasKim 0 873 Friday, October 25, 2013 2:32 PM 
Simeprevir Earns Positive Internal Review from FDA ThomasKim 0 986 Tuesday, October 22, 2013 1:33 PM 
More Drugs Show Promise in Fighting Hepatitis C - HealthDay Article ThomasKim 0 1433 Thursday, August 15, 2013 11:36 AM 
Gilead applies for FDA approval for Sofosbuvir ThomasKim 0 3795 Tuesday, April 9, 2013 1:36 PM 
J&J, Gilead combo drug therapy clears hep C in 100% of Phase IIa cohort ThomasKim 0 3971 Monday, March 4, 2013 1:00 PM 
Gilead Passes Two Phase III Test with HCV Pill ThomasKim 0 4013 Monday, February 4, 2013 4:01 PM 
Gilead Successfully Completes Fourth Phase III Study tkim 0 3757 Tuesday, February 19, 2013 1:03 PM 
Bristol-Myers Squibb Files for FDA Approval of NS5A Drug Combination tkim@idsociety.org 0 2 Thursday, April 10, 2014 1:50 PM 
Merck Unveils Interim Phase II Results tkim@idsociety.org 0 3 Thursday, April 10, 2014 1:46 PM 
Spurred by pricey Gilead hep C drug, payers cook up new cost-control moves tkim@idsociety.org 0 376 Monday, January 27, 2014 1:44 PM 
Phase III Results for Gilead Hep C Combo tkim@idsociety.org 0 549 Wednesday, December 18, 2013 12:51 PM 
Key hep C protein revealed, paving the way for new vaccines tkim@idsociety.org 0 581 Wednesday, December 4, 2013 7:57 AM 
AbbVie steps closer to FDA filing as first hep C PhIII delivers promising results tkim@idsociety.org 0 677 Monday, November 18, 2013 1:45 PM 
FDA Approved Changes to Incivek (telaprevir) Product Labeling to Include OPTIMIZE Trial Results tkim@idsociety.org 0 882 Wednesday, October 30, 2013 7:56 AM 
Gilead's Sofosbuvir Gains FDA Panel Approval tkim@idsociety.org 0 859 Monday, October 28, 2013 1:14 PM 
FDA Internal Review of Sofosbuvir tkim@idsociety.org 0 934 Wednesday, October 23, 2013 1:21 PM 
Clinicians Wait for Next Wave of Hepatitis C Antivirals - By: Debra Gordon tkim@idsociety.org 0 2981 Tuesday, June 11, 2013 3:43 PM 
Bristol-Myers gains FDA breakthrough track for HCV drug approval tkim@idsociety.org 0 3773 Thursday, April 25, 2013 2:00 PM 
 

| HIVMA | Contact Us

© Copyright IDSA 2013 Infectious Diseases Society of America

Full Site Mobile Site